Dr. Mauricio Concha, MD

Dr. Concha practices at Intercoastal Medical Group Inc in Sarasota, Florida.

Dr. Concha's NPI, 1093787780, was assigned on February 6, 2006. Dr. Concha graduated from Institute of Health Sciences Medellin Faculty of Medicine in 1986. Dr. Concha holds Florida license ME69547.

Dr. Concha's primary practice is Intercoastal Medical Group Inc, at 943 S Beneva Rd, Sarasota, FL 34232 in Sarasota County. The practice phone is (941) 955-1108.

Dr. Concha's primary practice is Intercoastal Medical Group Inc in Sarasota, Florida. Dr. Concha is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Intercoastal Medical Group. Dmand AI also links Dr. Concha to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Concha practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Concha's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Concha is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Concha is licensed in Florida.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and head injury among the conditions Dr. Concha treats.

CMS data shows 2,146 Medicare services from Dr. Concha across 20 procedure codes in 2024, for 864 Medicare patients. Medicare paid $135,529 for them.

CMS counts 864 Medicare patients who saw Dr. Concha in 2024. The largest group is 75 to 84, with 375 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Concha's median patient age at 79, with 46% women.

In 2024, Dr. Concha wrote 1,262 Medicare Part D claims for 319 patients. 89% of them were for generic drugs. CMS names the drug for 991 of them, across 32 drugs with 11 or more claims each, at $152,591 in total drug cost. In 2023, CMS named 980 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Concha for performance year 2024, reported individually. Dr. Concha accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 27 papers to Dr. Concha, published from 2012 to 2024. The most frequent topics are HIV-1, Neuropsychological Tests and AIDS Dementia Complex. Dr. Concha has published most often in CNS Spectr. Dr. Concha's most frequent co-authors are Karl Goodkin, MD, PhD, Sebastian Koch, MD and Jose G. Romano.

Dmand AI links Dr. Concha to 10 clinical trials, 2 of them phase 2/3 studies. 1 is still active or recruiting. Conditions studied include Stroke, Cognitive Dysfunction and Ischemic Stroke. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Concha that name 5 trials.

CMS Open Payments shows 678 general payments to Dr. Concha from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 55% of the total. Portola Pharmaceuticals, LLC paid the most, $162,280. It also lists 15 research payments totaling $30,944 from 2016 to 2023, naming 5 clinical trials.

Dmand AI lists 2 awards for Dr. Concha, most recently Sarasota Magazine: Top Doctors in 2014.

Dr. Concha graduated from Institute of Health Sciences Medellin Faculty of Medicine in 1986. Dr. Concha is a member of AAN.

Dr. Concha is in network with 9 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.